Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 2,741 | 2,756 | 2,885 | 424 | 145 |
| Operating Income | -2,741 | -2,756 | -2,885 | -424 | -145 |
| Other Income | 0 | 0 | 0 | 64 | 4 |
| Pre-tax Income | -2,741 | -2,756 | -2,885 | -360 | -141 |
| Net Income Continuous | -2,741 | -2,756 | -2,885 | -360 | -141 |
| Net Income | $-2,741 | $-2,756 | $-2,885 | $-360 | $-141 |
| EPS Basic Total Ops | -8.13 | -16.33 | -34.33 | -0.06 | -0.02 |
| EPS Basic Continuous Ops | -8.13 | -16.33 | -34.33 | -0.25 | -0.10 |
| EPS Diluted Total Ops | -8.13 | -16.33 | -34.33 | -0.06 | -0.02 |
| EPS Diluted Continuous Ops | -8.13 | -16.33 | -34.33 | -0.25 | -0.10 |
| EBITDA(a) | $-2,727 | $-2,756 | $-2,885 | $-424 | $-145 |